Weight Loss Supplement

Hydroxycut

204 adverse event reports submitted to the FDA · 2004–2025 · Data current as of June 3, 2026

These are reports submitted to the FDA. A report does not mean the product caused the effect. Counts reflect reporting activity, not how common an effect is.

Most Reported Reactions

Top 10 reactions from 204 reports. One report may include multiple reactions — reaction totals may exceed the report count.

Fatigue

Nausea

Liver Function Test Abnormal

Jaundice

Vomiting

Pain

Abdominal Pain

Dizziness

Abdominal Pain Upper

Asthenia

Reported Outcomes

Outcome categories as recorded in FDA reports. One report may include multiple outcomes.

Outcome	Reports
Hospitalization	99
Other Serious or Important Medical Event	98
Visited a Health Care Provider	60
Life Threatening	42
Visited Emergency Room	37
Required Intervention	24
Disability	18
Other Serious Outcome	17
Other Outcome	13
Death	6

Who Reported

Reporter demographics where available. Many reports do not include age or gender data.

Age

Under 18

18–34

35–49

50–64

65–79

80+

Unknown

170 reports had age data; 34 unknown.

Gender

Male

Female

102

Unknown/Not Reported

Reports by Year

Annual report counts from 2004–2025. Spike years may reflect recalls, media coverage, or litigation rather than changes in the product.

'04

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Hover bars for exact counts.

Context about this data: Reports concentrated in 2009, coinciding with FDA warning letters and the hepatotoxicity-linked market withdrawal that year.

← View all Hydroxycut products in FDA data

Data Source

This page presents data from the FDA's CFSAN Adverse Event Reporting System (CAERS) via the openFDA API. Reports are voluntary and unverified. The FDA has not concluded that this product caused any reported event.

View openFDA CAERS data ↗ · About our methodology · How to read this data